Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

G. Horneff, N. Ruperto, H. Brunner, P. Quartier, T. Constantin, E. Alexeeva, I. Kone-Paut, K. Marzan, N. Wulffraat, R. Schneider, S. Padeh, V. Chasnyk, C. Wouters, J. Kummerle Deschner, T. Kallinich, B. Lauwerys, E. Haddad, E. Nasonov, M. Trachana, O. VougioukaK. Abrams, K. Leon, K. Lheritier, A. Martini, D. Lovell

Research output: Contribution to journalArticle

Original languageEnglish
Article numberO83
JournalPediatric Rheumatology
Volume13
Issue number1
DOIs
Publication statusPublished - Sep 28 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this

Horneff, G., Ruperto, N., Brunner, H., Quartier, P., Constantin, T., Alexeeva, E., Kone-Paut, I., Marzan, K., Wulffraat, N., Schneider, R., Padeh, S., Chasnyk, V., Wouters, C., Deschner, J. K., Kallinich, T., Lauwerys, B., Haddad, E., Nasonov, E., Trachana, M., ... Lovell, D. (2015). Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever. Pediatric Rheumatology, 13(1), [O83]. https://doi.org/10.1186/1546-0096-13-S1-O83